NRAS and acute myeloid leukemia: A meta-analysis evaluated the impact of RAS mutations on the overall survival of adult and pediatric patients with AML; surprisingly, the researchers found no significant prognostic effect of RAS mutations on adult patients’ survival but noted that NRAS mutations may be a vital prognostic marker in children with AML [14].